Lp-PLA2 monoclonal antibody

Ref. 3D-10-2846

Produktinformation

• Name: Lp-PLA2 monoclonal antibody

Beschreibung

Lp-PLA2 monoclonal antibody is a highly specialized antibody that targets lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme involved in the development of atherosclerosis. This monoclonal antibody has been extensively studied and shown to inhibit the activity of Lp-PLA2, leading to reduced inflammation and plaque formation in arteries.

Using advanced techniques such as flow assay and electrochemical impedance spectroscopy, researchers have demonstrated the effectiveness of this monoclonal antibody in inhibiting Lp-PLA2 activity. It has also been shown to induce fas-mediated apoptosis in activated immune cells, further reducing inflammation.

In addition to its anti-inflammatory properties, this monoclonal antibody has been found to have antiapoptotic effects by inhibiting caspase activity. This can help preserve cell viability and prevent cell death in various pathological conditions.

The use of Lp-PLA2 monoclonal antibody has shown promising results in preclinical

• Marke: Biosynth